CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma

A Schlüter, Patrick Weller, Oliver Kanaan, +12

BMC Cancer

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment.

Ivonne Nel, U. Jehn, Thomas Gauler, +1

PubMed

Individual Profiling of Circulating Tumor Cell Composition and Therapeutic Outcome in Patients with Hepatocellular Carcinoma

Ivonne Nel, Hideo A. Baba, Judith Ertle, +5

Translational Oncology

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

Patrick Weller, Ivonne Nel, Philipp Hassenkamp, +6

PLoS ONE

Circulating Tumor Cell Composition in Renal Cell Carcinoma

Ivonne Nel, Thomas Gauler, Kira Bublitz, +5

PLoS ONE

Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment

Ivonne Nel, Thomas Gauler, Wilfried Eberhardt, +4

British Journal of Cancer

<i>IGFBP1</i> in Epithelial Circulating Tumor Cells as a Potential Response Marker to Selective Internal Radiation Therapy in Hepatocellular Carcinoma

Ivonne Nel, Hideo A. Baba, Frank Weber, +4

Biomarkers in Medicine

FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo

Luzie Brückner, Annika Reinshagen, Ngoc Anh Hoang, +6

Cancers

GynecologyPathologyCancer BiologyTumor BiologyOvarian Cancer +15

Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma

Ivonne Nel, Paul David, Guido Gerken, +1

Hepatology International

Tumor BiologyHepatologyHepatocellular CarcinomaMedicineBiological Microenvironments +9

An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors

A Kreklau, Ivonne Nel, Sabine Kasimir‐Bauer, +3

In Vivo